These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29225963)

  • 1. The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course.
    Jankauskiene J; Jarusaitiene D
    J Ophthalmol; 2017; 2017():4853905. PubMed ID: 29225963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.
    Jarusaitiene D; Verkauskiene R; Jasinskas V; Jankauskiene J
    Int J Endocrinol; 2016; 2016():8129497. PubMed ID: 27413373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    Bayarmunkh O; Ganbold C; Das S; Davaatseren U; Minjuurdorj NE; Jav S
    PLoS One; 2022; 17(11):e0277055. PubMed ID: 36395261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proptosis is associated with thiol-disulfide in patients with Graves' ophthalmopathy.
    Acibucu F; Öztürk DD; Kizildag C; Aslan MZ; Gulumsek E; Sumbul MS; Neselioglu S; Erel O; Sen S; Bankir M; Sumbul HE
    Arch Endocrinol Metab; 2022 Apr; 66(2):191-197. PubMed ID: 35315985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
    Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
    Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immunomodulators in the treatment of Graves' ophthalmopathy.
    Salvi M; Vannucchi G; Campi I; Currò N; Beck-Peccoz P
    Ann Endocrinol (Paris); 2008 Apr; 69(2):153-6. PubMed ID: 18417090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
    Lanzolla G; Puccinelli L; Giudetti M; Comi S; Menconi F; Maglionico MN; Posarelli C; Figus M; Marcocci C; Marinò M
    J Endocrinol Invest; 2023 Feb; 46(2):337-344. PubMed ID: 36030301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features of Graves' Ophthalmopathy and Impact of Enalapril on the Course of Mild Graves' Ophthalmopathy: A Pilot Study.
    Ataabadi G; Dabbaghmanesh MH; Owji N; Bakhshayeshkaram M; Montazeri-Najafabady N
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):139-148. PubMed ID: 31345156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.
    Reddy SV; Jain A; Yadav SB; Sharma K; Bhatia E
    Indian J Med Res; 2014 Jan; 139(1):99-104. PubMed ID: 24604044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of oculometric variables in Graves' ophthalmopathy.
    Miot HA; Fernandes LP; Jorge EN; Pivotto DR; Nogueira CR; Mazeto GM
    Clinics (Sao Paulo); 2009; 64(9):885-9. PubMed ID: 19759882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
    Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
    J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy.
    He M; Wang Y; Wang J; Sui J; Ding X; Chen Z; Zhang M; Zhao Y; Xie B; Shi B
    Cytokine; 2020 Mar; 127():154998. PubMed ID: 31972501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy.
    Bozkirli E; Bakiner OS; Ersozlu Bozkirli ED; Eksi Haydardedeoglu F; Sizmaz S; Torun AI; Ertorer ME
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):962-7. PubMed ID: 25400133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
    Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 18 and transforming growth factor beta1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
    Int Immunopharmacol; 2003 Apr; 3(4):549-52. PubMed ID: 12689659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral selenium improved the disease activity in patients with mild Graves' orbitopathy.
    Almanza-Monterrubio M; Garnica-Hayashi L; Dávila-Camargo A; Nava-Castañeda Á
    J Fr Ophtalmol; 2021 May; 44(5):643-651. PubMed ID: 33863564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Appraisal of the Preventive Effect of Statins on the Development of Graves' Ophthalmopathy: A Hospital-Based Cohort Study.
    Hsu GC; Shih SR; Chang FY; Liao SL; Wei YH
    Ophthalmol Ther; 2024 Jun; 13(6):1499-1511. PubMed ID: 38581604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis.
    Li HX; Xiang N; Hu WK; Jiao XL
    J Endocrinol Invest; 2016 Nov; 39(11):1225-1233. PubMed ID: 27220843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.